COVID-19 and influenza vaccine-hesitancy subgroups.

Publication date: May 14, 2024

Health communicators are faced with the challenge that people can hesitate vaccines for different reasons. Our aim was to identify and describe the qualities of distinct COVID-19 and influenza vaccine-hesitancy subgroups to facilitate the development of tailored vaccine-hesitancy communication. In two studies, we used agglomerative hierarchical cluster analysis to identify COVID-19 (N = 554) and influenza (N = 539) vaccine-hesitancy subgroups in the general population based on nine vaccine hesitancy-related variables (intent to get vaccinated, perceived vaccine safety, perceived vaccine efficacy, perceived disease threat, perceived vaccination responsibility, perceived vaccination convenience, distrust in authorities, conspiracy mentality, and reliance on anecdotal testimonies). We identified and described six distinct COVID-19 vaccine-hesitancy subgroups (the Vaccination Positive, the Ambivalent, the Fearing Skeptic, the Unconvinced, the Constrained Skeptic, and the Vaccination Opponent), and three influenza vaccine-hesitancy subgroups (the Vaccination Positive, the Complacent, and the Vaccination Opponent), with different levels of hesitancy. We discuss the implications of the results for health communicators. Our results shed light on the (dis)similarities between people who hesitate COVID-19 and influenza vaccines and suggest that there is greater variety in hesitancy concerning COVID-19 vaccinations than influenza vaccinations. These findings can be used to design and test tailored vaccination messages.

Open Access PDF

Concepts Keywords
Covid Adolescent
Influenza Adult
Skeptic Aged
Vaccine COVID-19
COVID-19 Vaccines
COVID-19 Vaccines
Female
Humans
Influenza Vaccines
Influenza Vaccines
Influenza, Human
Male
Middle Aged
SARS-CoV-2
Surveys and Questionnaires
Vaccination
Vaccination Hesitancy
Young Adult

Semantics

Type Source Name
disease MESH COVID-19
disease MESH influenza
disease VO vaccine
disease VO population
disease VO vaccinated
disease VO vaccine efficacy
disease VO vaccination
disease VO COVID-19 vaccine
disease VO influenza vaccines
drug DRUGBANK Hydroxyethyl Starch
disease VO effective
disease VO efficient
drug DRUGBANK Polyethylene glycol
disease VO unvaccinated
disease VO H1N1 Influenza vaccine
drug DRUGBANK Ranitidine
disease VO Optaflu
disease IDO intervention
disease VO vaccine dose
drug DRUGBANK Aspartame
drug DRUGBANK Cysteamine
drug DRUGBANK Coenzyme M
disease VO time
disease VO ineffective
disease MESH Infectious Diseases
drug DRUGBANK Trestolone
disease VO effectiveness
disease VO Canada
disease MESH syndromes
disease MESH mental disorders
disease VO immunization
disease MESH infections
disease MESH education level

Original Article

(Visited 1 times, 1 visits today)